Mankind Pharma enters into in-licensing agreement with Betta Pharmaceuticals for Ensartinib EP News Bureau Nov 16, 2026 Strategic agreement to strengthen Mankind Pharma’s oncology portfolio with a US FDA-approved targeted therapy for ALK-positive…